BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24013228)

  • 41. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
    Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of tumor receptor heterogeneity on the response to anti-angiogenic cancer treatment.
    Li D; Finley SD
    Integr Biol (Camb); 2018 Apr; 10(4):253-269. PubMed ID: 29623971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor.
    Rodriguez-Manzaneque JC; Lane TF; Ortega MA; Hynes RO; Lawler J; Iruela-Arispe ML
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12485-90. PubMed ID: 11606713
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lung stem cell differentiation in mice directed by endothelial cells via a BMP4-NFATc1-thrombospondin-1 axis.
    Lee JH; Bhang DH; Beede A; Huang TL; Stripp BR; Bloch KD; Wagers AJ; Tseng YH; Ryeom S; Kim CF
    Cell; 2014 Jan; 156(3):440-55. PubMed ID: 24485453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endothelial Cords Promote Tumor Initial Growth prior to Vascular Function through a Paracrine Mechanism.
    Zhao C; Zhang W; Zhao Y; Yang Y; Luo H; Ji G; Dong E; Deng H; Lin S; Wei Y; Yang H
    Sci Rep; 2016 Jan; 6():19404. PubMed ID: 26762853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers.
    Zhang Y; Zheng D; Zhou T; Song H; Hulsurkar M; Su N; Liu Y; Wang Z; Shao L; Ittmann M; Gleave M; Han H; Xu F; Liao W; Wang H; Li W
    Nat Commun; 2018 Oct; 9(1):4080. PubMed ID: 30287808
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1.
    Lee YJ; Koch M; Karl D; Torres-Collado AX; Fernando NT; Rothrock C; Kuruppu D; Ryeom S; Iruela-Arispe ML; Yoon SS
    Cancer Res; 2010 Feb; 70(3):948-56. PubMed ID: 20103648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop.
    Coffman LG; Choi YJ; McLean K; Allen BL; di Magliano MP; Buckanovich RJ
    Oncotarget; 2016 Feb; 7(6):6916-32. PubMed ID: 26755648
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BMP4 is a novel transcriptional target and mediator of mammary cell migration downstream of the Hippo pathway component TAZ.
    Lai D; Yang X
    Cell Signal; 2013 Aug; 25(8):1720-8. PubMed ID: 23673366
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Decorin induces rapid secretion of thrombospondin-1 in basal breast carcinoma cells via inhibition of Ras homolog gene family, member A/Rho-associated coiled-coil containing protein kinase 1.
    Neill T; Jones HR; Crane-Smith Z; Owens RT; Schaefer L; Iozzo RV
    FEBS J; 2013 May; 280(10):2353-68. PubMed ID: 23350987
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of tumor-derived SMAD4 enhances primary tumor growth but not metastasis following BMP4 signalling.
    Chi LH; Redfern AD; Roslan S; Street IP; Burrows AD; Anderson RL
    Cell Commun Signal; 2024 Apr; 22(1):248. PubMed ID: 38689334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determination of the CD148-Interacting Region in Thrombospondin-1.
    Takahashi K; Sumarriva K; Kim R; Jiang R; Brantley-Sieders DM; Chen J; Mernaugh RL; Takahashi T
    PLoS One; 2016; 11(5):e0154916. PubMed ID: 27149518
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors.
    Gustavsson H; Tesan T; Jennbacken K; Kuno K; Damber JE; Welén K
    BMC Cancer; 2010 Jun; 10():288. PubMed ID: 20546609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrated RNA-seq and DNase-seq analyses identify phenotype-specific BMP4 signaling in breast cancer.
    Ampuja M; Rantapero T; Rodriguez-Martinez A; Palmroth M; Alarmo EL; Nykter M; Kallioniemi A
    BMC Genomics; 2017 Jan; 18(1):68. PubMed ID: 28077088
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppression of thrombospondin-1 expression during uveal melanoma progression and its potential therapeutic utility.
    Wang S; Neekhra A; Albert DM; Sorenson CM; Sheibani N
    Arch Ophthalmol; 2012 Mar; 130(3):336-41. PubMed ID: 22411663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thrombospondin-1 gene expression affects survival and tumor spectrum of p53-deficient mice.
    Lawler J; Miao WM; Duquette M; Bouck N; Bronson RT; Hynes RO
    Am J Pathol; 2001 Nov; 159(5):1949-56. PubMed ID: 11696456
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paracrine signals from liver sinusoidal endothelium regulate hepatitis C virus replication.
    Rowe IA; Galsinh SK; Wilson GK; Parker R; Durant S; Lazar C; Branza-Nichita N; Bicknell R; Adams DH; Balfe P; McKeating JA
    Hepatology; 2014 Feb; 59(2):375-84. PubMed ID: 23775568
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1.
    Hulsurkar M; Li Z; Zhang Y; Li X; Zheng D; Li W
    Oncogene; 2017 Mar; 36(11):1525-1536. PubMed ID: 27641328
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thrombospondin-1 signaling through CD47 inhibits cell cycle progression and induces senescence in endothelial cells.
    Gao Q; Chen K; Gao L; Zheng Y; Yang YG
    Cell Death Dis; 2016 Sep; 7(9):e2368. PubMed ID: 27607583
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Id-1B, an alternatively spliced isoform of the inhibitor of differentiation-1, impairs cancer cell malignancy through inhibition of proliferation and angiogenesis.
    Nguewa P; Manrique I; Díaz R; Redrado M; Parrondo R; Perez-Stable C; Calvo A
    Curr Mol Med; 2014 Jan; 14(1):151-62. PubMed ID: 24295493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.